vs

Side-by-side financial comparison of Caledonia Mining Corp Plc (CMCL) and NATIONAL RESEARCH CORP (NRC). Click either name above to swap in a different company.

Caledonia Mining Corp Plc is the larger business by last-quarter revenue ($46.9M vs $35.2M, roughly 1.3× NATIONAL RESEARCH CORP). Caledonia Mining Corp Plc runs the higher net margin — 7.0% vs 5.1%, a 1.9% gap on every dollar of revenue. On growth, Caledonia Mining Corp Plc posted the faster year-over-year revenue change (13.8% vs -4.6%). Over the past eight quarters, Caledonia Mining Corp Plc's revenue compounded faster (17.1% CAGR vs -0.2%).

Hochschild Mining plc is a leading British-based silver and gold mining business operating in North, Central, and South America. It is headquartered in Lima, Peru, with a corporate office in London, is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The main shareholder is the Peruvian businessman Eduardo Hochschild.

National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.

CMCL vs NRC — Head-to-Head

Bigger by revenue
CMCL
CMCL
1.3× larger
CMCL
$46.9M
$35.2M
NRC
Growing faster (revenue YoY)
CMCL
CMCL
+18.4% gap
CMCL
13.8%
-4.6%
NRC
Higher net margin
CMCL
CMCL
1.9% more per $
CMCL
7.0%
5.1%
NRC
Faster 2-yr revenue CAGR
CMCL
CMCL
Annualised
CMCL
17.1%
-0.2%
NRC

Income Statement — Q3 FY2024 vs Q4 FY2025

Metric
CMCL
CMCL
NRC
NRC
Revenue
$46.9M
$35.2M
Net Profit
$3.3M
$1.8M
Gross Margin
41.2%
Operating Margin
18.6%
13.3%
Net Margin
7.0%
5.1%
Revenue YoY
13.8%
-4.6%
Net Profit YoY
-33.3%
-72.6%
EPS (diluted)
$0.13
$49.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCL
CMCL
NRC
NRC
Q4 25
$35.2M
Q3 25
$34.6M
Q2 25
$34.0M
Q1 25
$33.6M
Q4 24
$36.9M
Q3 24
$46.9M
$35.8M
Q2 24
$50.1M
$35.0M
Q1 24
$38.5M
$35.3M
Net Profit
CMCL
CMCL
NRC
NRC
Q4 25
$1.8M
Q3 25
$4.1M
Q2 25
$-106.0K
Q1 25
$5.8M
Q4 24
$6.6M
Q3 24
$3.3M
$5.7M
Q2 24
$10.2M
$6.2M
Q1 24
$2.1M
$6.4M
Gross Margin
CMCL
CMCL
NRC
NRC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
41.2%
Q2 24
45.8%
Q1 24
35.9%
Operating Margin
CMCL
CMCL
NRC
NRC
Q4 25
13.3%
Q3 25
22.4%
Q2 25
4.7%
Q1 25
25.6%
Q4 24
26.0%
Q3 24
18.6%
22.3%
Q2 24
32.2%
25.3%
Q1 24
13.8%
24.8%
Net Margin
CMCL
CMCL
NRC
NRC
Q4 25
5.1%
Q3 25
11.9%
Q2 25
-0.3%
Q1 25
17.2%
Q4 24
17.8%
Q3 24
7.0%
15.9%
Q2 24
20.3%
17.6%
Q1 24
5.4%
18.0%
EPS (diluted)
CMCL
CMCL
NRC
NRC
Q4 25
$49.58
Q3 25
$0.18
Q2 25
$-0.01
Q1 25
$0.25
Q4 24
$0.27
Q3 24
$0.13
$0.24
Q2 24
$0.42
$0.26
Q1 24
$0.07
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCL
CMCL
NRC
NRC
Cash + ST InvestmentsLiquidity on hand
$7.2M
$4.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$231.0M
$14.0M
Total Assets
$339.7M
$134.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCL
CMCL
NRC
NRC
Q4 25
$4.1M
Q3 25
$2.2M
Q2 25
$5.3M
Q1 25
$2.5M
Q4 24
$4.2M
Q3 24
$7.2M
$3.5M
Q2 24
$15.4M
$485.0K
Q1 24
$1.8M
$1.7M
Total Debt
CMCL
CMCL
NRC
NRC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$48.7M
Q2 24
$33.3M
Q1 24
$35.2M
Stockholders' Equity
CMCL
CMCL
NRC
NRC
Q4 25
$14.0M
Q3 25
$14.3M
Q2 25
$21.3M
Q1 25
$29.7M
Q4 24
$31.3M
Q3 24
$231.0M
$34.6M
Q2 24
$231.1M
$40.2M
Q1 24
$220.3M
$36.9M
Total Assets
CMCL
CMCL
NRC
NRC
Q4 25
$134.9M
Q3 25
$135.7M
Q2 25
$141.4M
Q1 25
$135.2M
Q4 24
$132.5M
Q3 24
$339.7M
$131.8M
Q2 24
$338.5M
$119.1M
Q1 24
$321.8M
$120.9M
Debt / Equity
CMCL
CMCL
NRC
NRC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.41×
Q2 24
0.83×
Q1 24
0.95×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCL
CMCL
NRC
NRC
Operating Cash FlowLast quarter
$4.6M
$7.2M
Free Cash FlowOCF − Capex
$6.1M
FCF MarginFCF / Revenue
17.2%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
1.40×
3.99×
TTM Free Cash FlowTrailing 4 quarters
$15.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCL
CMCL
NRC
NRC
Q4 25
$7.2M
Q3 25
$13.8M
Q2 25
$-1.1M
Q1 25
$6.6M
Q4 24
$6.4M
Q3 24
$4.6M
$9.4M
Q2 24
$19.1M
$6.8M
Q1 24
$12.0M
Free Cash Flow
CMCL
CMCL
NRC
NRC
Q4 25
$6.1M
Q3 25
$10.2M
Q2 25
$-4.1M
Q1 25
$3.7M
Q4 24
$1.9M
Q3 24
$7.8M
Q2 24
$1.5M
Q1 24
$7.9M
FCF Margin
CMCL
CMCL
NRC
NRC
Q4 25
17.2%
Q3 25
29.4%
Q2 25
-12.2%
Q1 25
10.9%
Q4 24
5.2%
Q3 24
21.8%
Q2 24
4.3%
Q1 24
22.4%
Capex Intensity
CMCL
CMCL
NRC
NRC
Q4 25
3.2%
Q3 25
10.4%
Q2 25
8.8%
Q1 25
8.9%
Q4 24
12.0%
Q3 24
4.5%
Q2 24
15.0%
Q1 24
11.7%
Cash Conversion
CMCL
CMCL
NRC
NRC
Q4 25
3.99×
Q3 25
3.34×
Q2 25
Q1 25
1.15×
Q4 24
0.97×
Q3 24
1.40×
1.66×
Q2 24
1.87×
1.10×
Q1 24
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons